Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Arthur Levin, Dennis Ausiello

Premium

Miragen Therapeutics has named Arthur Levin as its new executive vice president of research and development.

In this role, Levin will be responsible for advancing the company's drug candidates into clinical development and for leading drug-discovery research efforts, according to Miragen.

Levin previously served as chief development officer and president of Santaris Pharma's US operations. Before that, he was senior vice president of development at Isis Pharmaceuticals.


Alnylam Pharmaceuticals has appointed Dennis Ausiello to its board of directors and scientific advisory board.

Ausiello is currently a professor of clinical medicine at Harvard Medical School and chief of medicine at Massachusetts General Hospital.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.